DETERMINE is a cutting edge UK national precision medicine trial in rare cancers, testing a range of therapies specifically targeting key genetic changes in cancer cells.
Patient's referral
1. Patient referral
Contact a local investigator at an actively recruiting DETERMINE site to discuss your patient and initiate a referral.
2. Formal submission
After seeking consent from the patient to share their data, the local investigator will make a formal submission to the DETERMINE Molecular Tumour Board (MTB).
You'll need to provide any relevant clinical and genomic data.
3. Decision
The MTB will aim to return their decision to the local investigator within 5 working days.
The patient will need to sign an informed consent document for the specific treatment arm in the trial.
Participating sites
Participant site |
Investigator contact |
Adult/Paediatric |
Status |
Belfast Health and Social Care Trust, Belfast | Professor Vicky Coyle | Adults | RECRUITING |
Participant site |
Investigator contact |
Adult/Paediatric |
Status |
Beatson West of Scotland Cancer Centre (NHS Greater Glasgow & Clyde), Glasgow | Dr Patricia Roxburgh | Adults | RECRUITING |
Western General Hospital (NHS Lothian), Edinburgh | Dr Stefan Symeonides | Adults | RECRUITING |
Royal Hospital For Children Glasgow (NHS Greater Glasgow & Clyde), Glasgow | Dr Milind Ronghe | Paediatric | RECRUITING |
Participant site |
Investigator contact |
Adult/Paediatric |
Status |
Velindre University NHS Trust, Cardiff | Professor Robert Jones | Adults | RECRUITING |